Based on the key measurements obtained from Laboratory's financial statements, Laboratory of may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. As of now, Laboratory's Total Stockholder Equity is increasing as compared to previous years. The Laboratory's current Property Plant And Equipment Net is estimated to increase to about 3.2 B, while Other Current Liabilities is projected to decrease to under 490.9 M. Key indicators impacting Laboratory's financial strength include:
The financial analysis of Laboratory is a critical element in measuring its lifeblood. Investors should not minimize Laboratory's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Laboratory competes with Quest Diagnostics, Waters, Universal Health, Humana, and Hologic. Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina. Laboratory Corp operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 75000 people.
Comparative valuation techniques use various fundamental indicators to help in determining Laboratory's current stock value. Our valuation model uses many indicators to compare Laboratory value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratory competition to find correlations between indicators driving Laboratory's intrinsic value. More Info.
Laboratory of is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Laboratory of is roughly 2.15 . As of now, Laboratory's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Laboratory's earnings, one of the primary drivers of an investment's value.
Laboratory Systematic Risk
Laboratory's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Laboratory volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was nine with a total number of output elements of fifty-two. The Beta measures systematic risk based on how returns on Laboratory correlated with the market. If Beta is less than 0 Laboratory generally moves in the opposite direction as compared to the market. If Laboratory Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Laboratory is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Laboratory is generally in the same direction as the market. If Beta > 1 Laboratory moves generally in the same direction as, but more than the movement of the benchmark.
Laboratory Thematic Clasifications
Laboratory of is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Laboratory Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Laboratory's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Laboratory growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Laboratory help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Laboratory of. We use our internally-developed statistical techniques to arrive at the intrinsic value of Laboratory of based on widely used predictive technical indicators. In general, we focus on analyzing Laboratory Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Laboratory's daily price indicators and compare them against related drivers.
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance